Promethazine

Promethazine

SCHEMBL2118132

CC(CN1c2ccccc2Sc2ccccc21)N(C)C.O=C(O)/C=C/C(=O)O

nearest known ligand 0.76

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

HRH1

The experimentally established mechanism targets of Promethazine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HRH1 known ✓ P35367 2/20 0.76
CYP2D6 P10635 4/20 0.76
CHRM2 P08172 4/20 0.76
HTR1A P08908 4/20 0.76
CHRM1 P11229 4/20 0.76
ADRA1A P35348 4/20 0.76
OPRM1 P35372 4/20 0.76
DRD3 P35462 4/20 0.76
KCNH2 Q12809 4/20 0.76
LMNA P02545 4/20 0.76
ALOX15 P16050 3/20 0.76
HSD17B10 Q99714 3/20 0.76
ALDH1A1 P00352 3/20 0.76
ADRA2A P08913 3/20 0.76
DRD1 P21728 3/20 0.76
SLC6A2 P23975 3/20 0.76
SLC6A4 P31645 3/20 0.76
PTGS1 P23219 3/20 0.76
DRD2 P14416 2/20 0.76
ADRA2B P18089 2/20 0.76

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Promethazine SCHEMBL3682874 1.00 CYP2D6 (0.76) CYP2D6CHRM2HTR1ACHRM1ADRA1A
SCHEMBL7343108 0.89 CHRM2 (0.64) CYP2D6CHRM2HTR1ACHRM1ADRA1A
SCHEMBL7343102 0.89 CHRM2 (0.64) CYP2D6CHRM2HTR1ACHRM1ADRA1A
Promethazine SCHEMBL599319 0.88 CYP2D6 (0.78) CYP2D6CHRM2HTR1ACHRM1ADRA1A
SCHEMBL10367408 0.88 CYP2D6 (0.62) CYP2D6CHRM2HTR1ACHRM1ADRA1A
SCHEMBL10367407 0.88 CYP2D6 (0.62) CYP2D6CHRM2HTR1ACHRM1ADRA1A
Isothipendyl SCHEMBL19555662 0.88 KMT2A (0.81) CYP2D6CHRM2HTR1ACHRM1ADRA1A
Promethazine SCHEMBL26777 0.87 CYP2D6 (1.00) CYP2D6CHRM2HTR1ACHRM1ADRA1A
(S)-Promethazine SCHEMBL2900853 0.87 CYP2D6 (1.00) CYP2D6CHRM2HTR1ACHRM1ADRA1A
Promethazine SCHEMBL29372077 0.87 CYP2D6 (1.00) CYP2D6CHRM2HTR1ACHRM1ADRA1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9539216-B2 Multi-phase, multi-compartment, capsular delivery apparatus and methods for using same INNERCAP TECHNOLOGIES, INC. (US) 2017-01-10 US disclosed
US-20160136100-A1 MULTI-PHASE, MULTI-COMPARTMENT, CAPSULAR DELIVERY APPARATUS AND METHODS FOR USING SAME INNERCAP TECHNOLOGIES, INC. 2016-05-19 US disclosed
US-9241911-B2 Multi-phase, multi-compartment, capsular delivery apparatus and methods for using same INNERCAP TECHNOLOGIES, INC. 2016-01-26 US disclosed
US-20140212482-A1 MULTI-PHASE, MULTI-COMPARTMENT, CAPSULAR DELIVERY APPARATUS AND METHODS FOR USING SAME INNERCAP TECHNOLOGIES, INC. 2014-07-31 US disclosed
US-20130136791-A1 MULTI-PHASE, MULT-COMPARTMENT CAPSULAR DELIVERY APPARATUS AND METHODS FOR USING SAME MILLER FRED H (US) 2013-05-30 US disclosed
US-8361497-B2 Multi-phase, multi-compartment, capsular delivery apparatus and methods for using the same INNERCAP TECHNOLOGIES, INC. (US) 2013-01-29 US disclosed
US-20120093923-A1 Apparatus And Methods For Delivering A Plurality Of Medicaments For Management Of Co-Morbid Diseases, Illnesses, Or Conditions INNERCAP TECHNOLOGIES, INC. (US) 2012-04-19 US disclosed
US-20100233254-A1 MULTI-PHASE, MULTI-COMPARTMENT, CAPSULAR DELIVERY APPARATUS AND METHODS FOR USING THE SAME INNERCAP TECHNOLOGIES, INC. (US) 2010-09-16 US disclosed
US-20100221321-A1 Apparatus And Methods For Delivering A Plurality Of Medicaments For Management Of Co-Morbid Diseases, Illnesses Or Conditions INNERCAP TECHNOLOGIES, INC. (US) 2010-09-02 US disclosed
US-20050008690-A1 Supplying active materials in various phases in single dosage multicompartment capsule INNERCAP TECHNOLOGIES, INC. 2005-01-13 US disclosed